Scopus Biopharma Inc SCPS:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/09/24 EDT
0.0011UNCH (UNCH)
Volume
11
52 week range
0.00 - 0.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0011
  • 52 Week High0.10
  • 52 Week High Date05/10/23
  • 52 Week Low0.00
  • 52 Week Low Date04/08/24

Key Stats

  • Market Cap46,292.685
  • Shares Out42.08M
  • 10 Day Average Volume3,604.4
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-97.44

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0011
  • 52 Week High0.10
  • 52 Week High Date05/10/23
  • 52 Week Low0.00
  • 52 Week Low Date04/08/24
  • Market Cap46,292.685
  • Shares Out42.08M
  • 10 Day Average Volume3,604.4
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change-97.44

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-9.342M
  • ROE (TTM)-1,559.60%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Scopus Biopharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Scopus BioPharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of its immuno-oncology programs. The Company’s Duet Platform relies on an immuno-oncology with a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) within the tumor microenvironment, while alleviating tumor immunosuppression to jump-start T cell-mediated immune responses. The Duet Platform is comprised of three bifunctional...
Joshua Lamstein
Chairman of the Board, Principal Executive Officer
Robert Gibson
Vice Chairman of the Board, Treasurer, Secretary
Address
420 Lexington Ave Rm 300
New York, NY
10170-0399
United States